Cargando…
Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients
The primary objectives were to determine the prevalence of and identify variables associated with respiratory bacterial co-infection in COVID-19 inpatients. Secondary outcomes included length of stay and in-hospital mortality. Eighty-two (11.2%) of 735 COVID-19 inpatients had respiratory bacterial c...
Autores principales: | Bolker, Austin, Coe, Kelci, Smith, Jessica, Stevenson, Kurt, Wang, Shu-Hua, Reed, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481625/ https://www.ncbi.nlm.nih.gov/pubmed/34731685 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115558 |
Ejemplares similares
-
307. Predictors of Respiratory Bacterial Co-Infection in Hospitalized COVID-19 Patients
por: Reed, Erica E, et al.
Publicado: (2021) -
722. Effectiveness of Fidaxomicin versus Oral Vancomycin in the Treatment of Recurrent Clostridioides difficile
por: Rinaldi, Alyssa, et al.
Publicado: (2020) -
177. Clinical Outcomes of Daptomycin vs. Anti-Staphylococcal β-Lactams in Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bloodstream Infections
por: Agnello, Sydney, et al.
Publicado: (2019) -
599. Association between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
por: Aycock, Anna C, et al.
Publicado: (2022) -
1484. Impact of Combination Vs. Monotherapy on Clinical Outcomes Associated with Stenotrophomonas maltophilia Pneumonia
por: Shah, Megan, et al.
Publicado: (2018)